The average P/S ratio for BSX's competitors is 7.59, providing a benchmark for relative valuation. Boston Scientific Corp Corp (BSX) exhibits a P/S ratio of 7.82, which is 3.01% above the industry average. Given its robust revenue growth of 22.44%, this premium appearssustainable.